80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]王麗梅 林 授 何小蘭 詹友知 王 明.核酸檢測(cè)單反應(yīng)性獻(xiàn)血者歸隊(duì)情況分析[J].福建醫(yī)藥雜志,2019,41(04):12-16.
　WANG Limei,LIN Shou,HE Xiaolan,et al.Analysis for reentry of blood donors by single NAT reactive[J].FUJIAN MEDICAL JOURNAL,2019,41(04):12-16.
點(diǎn)擊復(fù)制

核酸檢測(cè)單反應(yīng)性獻(xiàn)血者歸隊(duì)情況分析()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
41
期數(shù):
2019年04期
頁碼:
12-16
欄目:
臨床研究
出版日期:
2019-08-15

文章信息/Info

Title:
Analysis for reentry of blood donors by single NAT reactive
文章編號(hào):
1002-2600(2019) 04-0012-05
作者:
王麗梅 林 授 何小蘭 詹友知 王 明1
福建省血液中心(福州 350004)
Author(s):
WANG Limei; LIN Shou; HE Xiaolan;  ZHAN Youzhi; WANG Ming
Fujian Blood Center,Fuzhou,Fujian 350004,China
關(guān)鍵詞:
獻(xiàn)血者歸隊(duì);  核酸檢測(cè);  核酸鑒別檢測(cè);  單反應(yīng)性
Keywords:
reentry of blood donor;  nucleic acid test;  NAT identification test;  single reactive
分類號(hào):
R446.62; R37; R193.3
文獻(xiàn)標(biāo)志碼:
B
摘要:
目的 分析核酸檢測(cè)(NAT)單反應(yīng)性獻(xiàn)血者的歸隊(duì)情況。方法 回溯2012-2017年我 中心無償獻(xiàn)血者血液NAT單反應(yīng)性和鑒別情況,以我中心在2016-2017年歸隊(duì)的233名獻(xiàn)血者為 研究對(duì)象,進(jìn)行ALT速率法檢測(cè),HBV、HCV、HIV、梅毒螺旋體(TP)兩種不同廠家ELISA試劑檢 測(cè),HBV、HCV、HIV單人份NAT檢測(cè)。并對(duì)其中歸隊(duì)檢測(cè)反應(yīng)性的11名獻(xiàn)血者進(jìn)行追蹤檢測(cè)。 結(jié)果 2012-2017年491 159名無償獻(xiàn)血者,0.33%血液NAT檢測(cè)單反應(yīng)性,其中30%鑒別為HBV DNA。233名歸隊(duì)獻(xiàn)血者中,24.5%(57/233)歸隊(duì)檢測(cè)反應(yīng)性,75.5%(176/233)歸隊(duì)檢測(cè)非反應(yīng) 性。233名歸隊(duì)獻(xiàn)血者中,76名既往鑒別為HBV DNA,44.7%(34/76)歸隊(duì)檢測(cè)非反應(yīng)性; 157名 既往鑒別為不可鑒別,90.4%(142/157)歸隊(duì)檢測(cè)非反應(yīng)性。11名追蹤試驗(yàn)獻(xiàn)血者追蹤檢測(cè)結(jié) 果為反應(yīng)性8名,非反應(yīng)性3名。結(jié)論 核酸檢測(cè)單反應(yīng)性獻(xiàn)血者歸隊(duì)有其必要性和現(xiàn)實(shí)意義; 血站應(yīng)根據(jù)實(shí)際情況,建立適合的核酸檢測(cè)單反應(yīng)性獻(xiàn)血者歸隊(duì)策略并不斷完善。
Abstract:
Objective To analyze reentry of blood donors by single NAT reactive.Methods Single NAT reactive and identification of volunteer blood donors in Fujian Blood Center from 2012 to 2017 were looked back.A total of 233 blood donors returned to be tested again in 2016-2017.All the samples were tested with ALT rate, HBV,HCV, HIV and TP by ELISA reagents from two different manufacturers, and multiplex NAT(HBV, HCV and HIV single person NAT).Eleven NAT reactive donors were tracked and detected.Results From 2012 to 2017,491 159 volunteer blood donors were tested.0.33% of them were single NAT reactive,and 30% of them were discriminated as HBV DNA.From 2016 to 2017, 233 deferred donors were back to test again,the results were 24.5%(57/233)NAT reactive,75.5%(176/233)NAT non-reactive.Among the 233 blood donors,76 donors were previously discriminated as HBV DNA, 44.7%(34/76)tested again were NAT non-reactive, 157 blood donors were previously non-discriminated reactive,and 90.4%(142/157)tested again were NAT non-reactive. Eleven NAT reactive blood donors were tracked,among them eight cases were NAT reactive,and three cases were NAT non-reactive.Conclusion Reentry of NAT reactive blood donors is very necessary and meaningful.Blood stations should be based on actual conditions,to establish a suitable strategy for reentry of donors by single NAT reactive,and constantly improve.

參考文獻(xiàn)/References:

[1] 李雪梅,楊春茂,楊春晴,等.獻(xiàn)血者HBsAg、抗-HCV、抗-HIV、抗-TP ELISA 檢測(cè)陽性與 確證試驗(yàn)的對(duì)比研究[J].中國(guó)輸血雜志,2013,26(6):541-543.
[2] Zou S,Dorsey K A,Notari E P,et al. Prevalence,incidence,and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing [J].Transfusion,2010,50(7): 1495-1504.
[3] 中國(guó)輸血協(xié)會(huì).反應(yīng)性獻(xiàn)血者屏蔽與歸隊(duì)指南[S]. 第2版.北京:血液質(zhì)量管理工作 委員會(huì),2015:2-14.
[4] 程麗姍,黃力勤,姚鳳蘭,等.美國(guó)FDA HIV-1 和HCV 核酸檢測(cè)程序、血液處置和獻(xiàn) 血者屏蔽與歸隊(duì)指引主要推薦及其啟示[J].中國(guó)輸血雜志,2018,31(6):693-697.
[5] 黃力勤,李舟,姚鳳蘭,等.美國(guó)FDA HIV-1 和HCV 核酸檢測(cè)程序、血液處置和獻(xiàn)血 者屏蔽與歸隊(duì)指引主要推薦及其啟示(下)[J]. 中國(guó)輸血雜志,2018,31(7):813-819.
[6] 姚鳳蘭,汪德海,查煒,等.核酸檢測(cè)單反應(yīng)性無償獻(xiàn)血者HBV感染狀態(tài)分析[J].國(guó)際 檢驗(yàn)醫(yī)學(xué)雜志,2017,38(11):1513-1516.
[7] 汪德海,王瑞,葛紅衛(wèi).血站核酸檢測(cè)實(shí)驗(yàn)室質(zhì)量監(jiān)控指標(biāo)應(yīng)用[J].中國(guó)輸血雜 志,2012,25(6):524-527.
[8] 梁浩堅(jiān),汪傳喜,許結(jié)儀,等.2011-2014廣州地區(qū)無償獻(xiàn)血者核酸檢測(cè)結(jié)果分析[J]. 中國(guó)醫(yī)藥科學(xué),2016,6(10):138-141.
[9] 林詩雅,王淏,李仲平,等.2015廣州地區(qū)無償獻(xiàn)血者核酸和ELISA檢測(cè)結(jié)果分析[J]. 臨床輸血與檢驗(yàn),2017,19(2):137-141.
[10] 趙紅娜,王藝芳,李俊英,等.核酸檢測(cè)與酶免檢測(cè)在鄭州地區(qū)血液篩查中的聯(lián)合應(yīng) 用[J].中國(guó)輸血雜志,2015,28(10):1269-1271.
[11] 鄧雪蓮,安萬新,梁曉華,等.大連市血液中心血清學(xué)檢測(cè)與核酸檢測(cè)并行的效果觀 察[J].中國(guó)輸血雜志,2012,25(1):38-40.
[12] 高智俊,蔡 茵,唐晴鈞,等.病毒核酸檢測(cè)在無償獻(xiàn)血者中的應(yīng)用及其質(zhì)量控制方 法的探討[J].臨床檢驗(yàn)與醫(yī)學(xué),2018,15(8):2799-2802.
[13] 黃力勤,姚鳳蘭,葛紅衛(wèi).核酸檢測(cè)系統(tǒng)聯(lián)檢與鑒別結(jié)果不一致原因分析[J].中國(guó) 輸血雜志,2016,29(8):802-806.
[14] 黃敏,傅強(qiáng),馬貴明,等.單人份核酸聯(lián)合ELISA血液篩查方案初探[J].中國(guó)輸血雜 志,2015,28(4):384-386.
[15] 任亞娜,周國(guó)平,王中英,等.核酸檢測(cè)反應(yīng)性獻(xiàn)血者歸隊(duì)方法學(xué)及可行性的初步研 究[J].中國(guó)輸血雜志,2017,30(7):818-821.
[16] 李微, 溫馨娜, 鄭慧麗.齊齊哈爾市無償獻(xiàn)血者血液HBV、HCV、HIV酶免檢測(cè)聯(lián)合 NAT檢測(cè)結(jié)果分析[J]. 中國(guó)繼續(xù)醫(yī)學(xué)教育,2016,8(21):36-37.
[17] Shyamala V.Nucleic acid technology testing for blood screening impact of individual donation and mini pool-NAT testing on analytical sensitivity,screening sensitivity and clinical sensitivity[J].ISBT Science Series,2014,9(2): 315-324.

備注/Memo

備注/Memo:
1 通信作者,E-mail:[email protected]
更新日期/Last Update: 2019-08-15